NOTICE: Labnodes now supports vumc.org email addresses. If your email changed, please update your profile today.
Iekuni Ichikawa
Last active: 1/25/2012

  1. Podocyte injury damages other podocytes. Matsusaka T, Sandgren E, Shintani A, Kon V, Pastan I, Fogo AB, Ichikawa I (2011) J Am Soc Nephrol 22(7): 1275-85
    › Primary publication · 21719786 (PubMed) · PMC3137575 (PubMed Central)
  2. Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice. Yamamoto S, Zuo Y, Ma J, Yancey PG, Hunley TE, Motojima M, Fogo AB, Linton MF, Fazio S, Ichikawa I, Kon V (2011) Nephrol Dial Transplant 26(8): 2491-7
    › Primary publication · 21245127 (PubMed) · PMC3203394 (PubMed Central)
  3. Induction of podocyte-derived VEGF ameliorates podocyte injury and subsequent abnormal glomerular development caused by puromycin aminonucleoside. Ma J, Matsusaka T, Yang HC, Zhong J, Takagi N, Fogo AB, Kon V, Ichikawa I (2011) Pediatr Res 70(1): 83-9
    › Primary publication · 21451433 (PubMed) · PMC3113658 (PubMed Central)
  4. Glomerular sclerosis is prevented during urinary tract obstruction due to podocyte protection. Matsusaka T, Kobayashi K, Kon V, Pastan I, Fogo AB, Ichikawa I (2011) Am J Physiol Renal Physiol 300(3): F792-800
    › Primary publication · 21177778 (PubMed) · PMC3064125 (PubMed Central)
  5. Fibrinogen that appears in Bowman's space of proteinuric kidneys in vivo activates podocyte Toll-like receptors 2 and 4 in vitro. Motojima M, Matsusaka T, Kon V, Ichikawa I (2010) Nephron Exp Nephrol 114(2): e39-47
    › Primary publication · 19887845 (PubMed) · PMC2857683 (PubMed Central)
  6. Angiotensin receptor blocker protection against podocyte-induced sclerosis is podocyte angiotensin II type 1 receptor-independent. Matsusaka T, Asano T, Niimura F, Kinomura M, Shimizu A, Shintani A, Pastan I, Fogo AB, Ichikawa I (2010) Hypertension 55(4): 967-73
    › Primary publication · 20142565 (PubMed) · PMC2887658 (PubMed Central)
  7. Renal dysfunction potentiates foam cell formation by repressing ABCA1. Zuo Y, Yancey P, Castro I, Khan WN, Khan W, Motojima M, Ichikawa I, Fogo AB, Linton MF, Fazio S, Kon V (2009) Arterioscler Thromb Vasc Biol 29(9): 1277-82
    › Primary publication · 19667109 (PubMed) · PMC2748735 (PubMed Central)
  8. Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis. Suzuki T, Matsusaka T, Nakayama M, Asano T, Watanabe T, Ichikawa I, Nagata M (2009) Am J Pathol 174(5): 1675-82
    › Primary publication · 19359523 (PubMed) · PMC2671256 (PubMed Central)
  9. An essential role of the universal polarity protein, aPKClambda, on the maintenance of podocyte slit diaphragms. Hirose T, Satoh D, Kurihara H, Kusaka C, Hirose H, Akimoto K, Matsusaka T, Ichikawa I, Noda T, Ohno S (2009) PLoS One 4(1): e4194
    › Primary publication · 19142224 (PubMed) · PMC2614475 (PubMed Central)
  10. Megalin contributes to the early injury of proximal tubule cells during nonselective proteinuria. Motoyoshi Y, Matsusaka T, Saito A, Pastan I, Willnow TE, Mizutani S, Ichikawa I (2008) Kidney Int 74(10): 1262-9
    › Primary publication · 18769366 (PubMed) · PMC2615689 (PubMed Central)